Latest Regulatory Progress News

Page 20 of 58
Immuron Limited reported a narrower half-year loss alongside record sales growth and FDA approval for its IMM-529 drug candidate, signalling promising clinical and commercial momentum.
Ada Torres
Ada Torres
25 Feb 2026
Firebrick Pharma reports a reduced half-year loss of $1.26 million while launching its Nasodine Throat Spray in Singapore and Fiji, with regulatory approval pending in the Philippines.
Ada Torres
Ada Torres
24 Feb 2026
Greenwing Resources has significantly enhanced the economics of its Que River Project following a sharp rise in key metal prices, nearly doubling projected cash flows and advancing a two-stage development plan.
Maxwell Dee
Maxwell Dee
24 Feb 2026
Clarity Pharmaceuticals reports another metastatic prostate cancer patient achieving undetectable disease markers in its Phase II SECuRE trial, reinforcing promising efficacy and safety of its Cu-SAR-bisPSMA radiopharmaceutical.
Ada Torres
Ada Torres
23 Feb 2026
Sunshine Metals has released a comprehensive scoping study for its Liontown Gold Operation in North Queensland, outlining a promising initial production target of approximately 75,000 ounces of gold and 654,000 ounces of silver. The study highlights strong financial metrics and a pathway to production by late 2026, with further resource updates expected.
Maxwell Dee
Maxwell Dee
16 Feb 2026
Aurizon Holdings reported a 9% rise in underlying EBITDA to $891 million for the half-year ending December 2025, driven by higher volumes and yields in coal and bulk segments. The company also raised its full-year dividend guidance and extended its share buy-back program.
Victor Sage
Victor Sage
16 Feb 2026
Sarytogan Graphite Limited has upgraded its Mineral Resource Estimate to include 5.4 million tonnes of Measured graphite, underpinning a multi-decade mine life in Kazakhstan. This milestone supports the ongoing Definitive Feasibility Study due mid-2026.
Maxwell Dee
Maxwell Dee
16 Feb 2026
Vysarn Limited and the Kariyarra Aboriginal Corporation have advanced their Kariyarra Water Scheme with a key groundwater licence application and a bid to supply bulk water to Port Hedland.
Maxwell Dee
Maxwell Dee
13 Feb 2026
Novo Resources has significantly increased the Exploration Target at its Belltopper Gold Project in Victoria, with multiple high-grade prospects across its Australian portfolio and drilling programs planned throughout 2026.
Maxwell Dee
Maxwell Dee
12 Feb 2026
Island Pharmaceuticals has confirmed the material significance of recent FDA feedback on its Galidesivir development pathway and addressed ASX queries on disclosure timing and capital raising activities.
Ada Torres
Ada Torres
10 Feb 2026
Memphasys Limited has secured Therapeutic Goods Administration approval for its Felix™ System two months ahead of schedule, enabling immediate commercial sales and clinical use in Australia.
Ada Torres
Ada Torres
9 Feb 2026
Memphasys has raised $800,000 through a share placement to accelerate the commercial expansion of its Felix™ System, following key regulatory approvals and initial revenue milestones.
Ada Torres
Ada Torres
6 Feb 2026

Browse the archive

Full archive